Mon 15 Feb 2010
- Fri 19 Feb 2010
Rubens Hotel, London, United Kingdom
|
|
Mon 07 Jun 2010
- Fri 11 Jun 2010
Berlin To be decided, Berlin, Germany
|
|
|
|
This popular, highly interactive and practical executive programme has been specifically designed by experts in business and management development from the pharmaceutical sector. Over the course of five days it will build upon your key management skills and provide you with the intellectual capital needed to excel as a high performance manager in this industry. The ‘Pharma Executive Mini- MBA’ consists of five modules based on the key areas of the MBA that have been especially tailored to develop the optimum management skills required within the pharma sector.
The nature of this programme is practical and hands-on rather than academic. Our expert faculty have unrivaled experience and expertise within their specific sector of the industry and will provide invaluable knowledge and wisdom. Through them, you will explore real-life examples of corporate practices and managerial skills as they share their consulting and business experience and provide a series of helpful, tried and tested frameworks and tools.
The aim of the ‘Pharma Executive Mini-MBA’ however is to harness not just the experiences of our presenters but to interact and share with your fellow delegates to gain insight from others in a similarly senior position within the industry. The programme consistently attracts delegates from high levels within the industry ensuring we bringing together the elite of the pharma world.
“Fabulous. All the content was relevant to what I do throughout the 5 days”
Sales and Marketing Director,
Brittania Pharmaceuticals Ltd
“An energising training course”
Sr Strategic Account Executive,
Quest Diagnostics Clinical Trials
“The course gave a great understanding of the high level decision making that is driving change in my current organisation”
Director of Business Development,
MDS Pharma Services
“Very useful. The trainers very skillfully kept pace and are obviously very knowledgable”
CMO,
R&D Pharmaceuticals
“Excellent programme. It accomplished a lot in a short period”
Director Biotechnology, Protein & Immunogenicity,
Covance
“The course provided an outstanding overview of the topics in each module. Most impressive was the relevance of the examples given”
Director of Business Development,
Brittania Pharmaceuticals Ltd
Please note that places on this programme are strictly limited to provide the optimum learning environment. Previous courses have sold out in advance. Please book your place early.
|
|
|
Who Will Attend?
This intensive programme is designed for Senior Management within any area of the Life Sciences industry. Specifically:
1. Managers who have influence across functional areas and who have to cope with ambiguous or difficult situations.
2. Those who are leading major projects or change within their organisations – either now or in the future.
3. Managers who require a short intensive time away from day-to-day pressures to think strategically about their business.
4. Functional support specialists who are either being promoted into a broader business role or who need to start developing a wider organisation perspective.
|
|
|
| |
|
“Excellent due to the high level of experience of the trainers”
Programme Director – Vaccines,
Crucell NV
|
|
| |
|
Course Leader
Programme presenters will include:
Dr Laura Brown BSc (Biochemistry), BSc (Psychology), Diploma in Clinical Science, PhD, MBA
Dr Laura Brown is an independent training consultant and Course Director of the MSc in Clinical Research at the University of Cardiff School of Pharmacy.
Laura Brown has more than 14 years’ experience in the pharmaceutical industry. She has worked for several companies including Wellcome, Hoechst Marion Roussel, Good Clinical Research Practices and Rostrum. She has worked as a Clinical Research Associate, Project Manager, Clinical Research Manager, an Auditor and as Head of Training of Rostrum she delivered both technical and personal skills courses.
Laura has a particular expertise in Clinical Research, GCP and project management. She was Chairman of the Institute of Clinical Research GCP Forum for six years, regularly writes on clinical research issues, GCP and project management. She is a member of the Editorial board of the Good Clinical Practice Journal.
In addition, Laura has an MBA, with specialisation in project management.
She is co-author of “Strategic Project Management” and “Be your own consultant” (Tomson Learning, 2001 Publications). She is also the author of SCRIP’s latest GCP guide.
Chris Dickin was trained as a management accountant with the Rolls Royce Aerospace Division in Derby, UK. Academically, he qualified as a professional accountant and gained a Masters degree in Financial Control. He is currently a full time, independent cost reduction consultant and financial trainer, working extensively throughout the world. He has worked with a range of pharma organisations including Johnson & Johnson and Eczacibasi.
John DR Jolley, BSc Pharm, FRPharmS, FCQI. Pharmaceutical Consultant
John has worked for the last 35 years in the Pharmaceutical Industry during which time he has held positions in Research, Production, Quality Assurance, Logistics and General Management. For 15 of these years he worked as Technical Director for Boehringer Ingelheim UK.
John is currently Managing Director to Pharma Consult (Europe) Ltd providing a wide range of pharmaceutical technical and personal in-house and public training courses for the pharmaceutical industry and specialising in;
Providing Qualified Person (Directive 2001/83 article 49/50) support in the manufacture of Active Pharmaceutical Ingredients (Inc Biological), medicines manufacture, clinical Trials and Product Distribution.
Understanding the process of drug development and the application of ICH Development Q8 in developing an Investigational Medicinal Product.
Applying the regulatory framework for Clinical trials and implementing the best practices in GCP and GMP for sponsors, Investigators, project management and Qualified Persons (GMP & PV).
Undertaking QA, GCP and GMP audits for pharmaceutical Clinical trials, Production and Distribution processes.
Applying the principals of risk management ( ICH –Q9) in Quality management systems for the development and manufacturing Pharmaceutical products.
Developing management skills in the dynamics of team building, creative communication, conflict resolution and effective negotiation.
For several years John has been assessing delegates applying for registration as a Qualified Person (QP) and is one of the joint authors of the EU Code of Practice for the QP, he has been a member of the Association of British Pharmaceutical Industries Technical committee and is currently a member of the council of the Royal Pharmaceutical Society of Great Britain.
Malcolm Ross qualified in the UK with a degree in Pharmacy and a PhD in Medicinal Chemistry. In his academic career he was a lecturer at the Welsh School of Pharmacy and later a Senior Lecturer in the Chemistry Department of Bar Ilan University.
Dr. Ross has over 25 years experience in the Generics Industry, the last 15 being at corporate level.
He has been intimately involved in strategic planning, pipeline management and related activities. His early industrial experience with Teva and Taro were directed primarily to the US markets but later as President of IPR, a company jointly owned by PAR and Merck Generics his role expanded to include development for both US and European markets. Until recently he was Director of Research and Development for the largest Pharmaceutical Company in Poland.
Technically Malcolm specializes in development, both of formulations and analytical methodologies and holds a number of patents for novel formulations. He has set up R&D departments from scratch and has been responsible for undertaking their upgrading to European standards. Experienced in GMP and QA issues Malcolm has carried out many audits in different companies around the world, both for API and Finished dosage forms. In 2006 Malcolm moved to Basel and established Generapharm, a training and consultancy company specializing in the Generics industry.
He is a frequent presenter at international conferences on a range of topics, from strategic matters, quality issues and project management through to technical subjects including formulation development and analytical procedures.
Malcolm is particularly well known for his clear and well thought out presentations illustrated with many real examples and delivered in lively style with a unique sense of humour.
Dr Graham Leask first trained as a Zoologist and studied Entomology at Imperial College London before beginning his career in agrochemicals research. After working in research at ICI he entered the Pharmaceutical Industry, where he worked in a number of marketing and general management roles for several of the top 10 pharmaceutical companies. Recent roles include Strategic Planning Director for Astra Corporate reporting to the executive board and responsible for strategy development. In which capacity he gained first hand work experience in the world’s top ten pharmaceutical markets.
Graham did an MBA before completing his PhD at Cranfield University and is now a member of the Economics and Strategy Group at Aston University where he specializes in the measurement of promotional investment and the relationship between strategy and shareholder value. Current research interests include;
1. How strategic groups, i.e. firms following similar strategies, explain performance.
2. The measurement of different sales and marketing activities in particular how different sales strategies contribute to performance.
3. Competitive Strategy in the Pharmaceutical Industry
4. Finding groups in data i.e. turning data into information through effective use of modern statistical computing methods.
Graham has published actively on the subject of health care reform and strategy in the healthcare and pharmaceutical industries. His most recent work on Strategic Groups was published in the Strategic Management Journal in 2007.